kSectionSeparatorToken Deputy Editor, North West DRUG testing specialist Cyprotex has warned profits will be below market expectations due to ``softer'' second half revenues.The Macclesfield firm, which develops software used by large pharmaceutical groups to predict the effect of medication, said its performance had been affected in recent weeks by pre-Christmas customer delays.In a trading statement the group said: ``While revenues up to the month of October were as expected, late November and December performance have been slightly softer than expected due to a delay in customers......for the full story register now for free or login below...
Cyprotex warns on profits